Detection and phase I metabolism of the 7‐azaindole‐derived synthetic cannabinoid 5F‐AB‐P7AICA including a preliminary pharmacokinetic evaluation-Reference-Cited by-同舟云学术

Detection and phase I metabolism of the 7‐azaindole‐derived synthetic cannabinoid 5F‐AB‐P7AICA including a preliminary pharmacokinetic evaluation

Published:2019-10-23 Issue:1 Volume:12 Page:78-91
ISSN:1942-7603
Container-title:Drug Testing and Analysis
language:en
Short-container-title:Drug Test Anal

Author:

Giorgetti Arianna¹²^ORCID,Mogler Lukas²³^ORCID,Haschimi Belal²³^ORCID,Halter Sebastian²³,Franz Florian²³^ORCID,Westphal Folker⁴,Fischmann Svenja⁴,Riedel Jan⁵,Pütz Michael⁵,Auwärter Volker²³^ORCID

Affiliation:

1. Legal Medicine and Toxicology University‐Hospital of Padova Italy

2. Institute of Forensic Medicine, Forensic Toxicology Medical Center ‐ University of Freiburg Germany

3. Faculty of Medicine University of Freiburg Germany

4. State Bureau of Criminal Investigation Schleswig‐Holstein Kiel Germany

5. Federal Criminal Police Office Forensic Science Institute Wiesbaden Germany

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.2692

Reference46 articles.

1. ‘Spice’ and other herbal blends: harmless incense or cannabinoid designer drugs?

2. Identification of a cannabimimetic indole as a designer drug in a herbal product

3. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).European Drug Report;2019: trends and developments. Publications Office of the European Union Lisbon.http://www.emcdda.europa.eu/publications/edr/trends-developments/2019Accessed July 17 2019

4. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products

5. Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism of ADB‐FUBIATA in zebrafish and pooled human liver microsomes investigated by liquid chromatography–high‐resolution mass spectrometry;Rapid Communications in Mass Spectrometry;2024-03-08

2. ADB‐HEXINACA—a novel synthetic cannabinoid with a hexyl substituent: phase I metabolism in authentic urine samples, a case report and prevalence on the German market;Drug Testing and Analysis;2024-02-13

3. Narrative Review of the Pharmacodynamics, Pharmacokinetics, and Toxicities of Illicit Synthetic Cannabinoid Receptor Agonists;Mini-Reviews in Medicinal Chemistry;2024-01

4. Log D_7.4 and plasma protein binding of synthetic cannabinoid receptor agonists and a comparison of experimental and predicted lipophilicity;Drug Testing and Analysis;2023-12-08

5. A study of major cannabinoids via Raman spectroscopy and density functional theory;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2023-12